{
    "clinical_study": {
        "@rank": "30019", 
        "arm_group": {
            "arm_group_label": "XP200 device RF treatments", 
            "arm_group_type": "Experimental", 
            "description": "Every subject in the study will undergo 4 treatments and will be followed up for 6 months with photoraphic 3 evaluations: before treatment, 3 and 6 months follow-up.  Photographs will be scored on a Fitzpatrick scale by 3 blinded evaluators."
        }, 
        "brief_summary": {
            "textblock": "To evaluate the wrinkle-reducing effects of 3.25-MHz radiofrequency (RF) energy delivered in\n      4 weekly applications to human periorbital skin area by grating pre- and 90-days post\n      treatment photographs on the Fitzpatrick Wrinkle Severity Scale (FWSS) by three blinded\n      evaluators."
        }, 
        "brief_title": "Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Periorbital Wrinkles", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  35-60 years old\n\n          -  periorbital wrinkles\n\n        Exclusion Criteria:"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795417", 
            "org_study_id": "XP200 3.25 MHZ RF"
        }, 
        "intervention": [
            {
                "arm_group_label": "XP200 device RF treatments", 
                "description": "Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device", 
                "intervention_name": "RF XP200", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "XP200 device RF treatments", 
                "description": "4 RF treatments of periorbital region on one side of the face", 
                "intervention_name": "XP200 RF device", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "wrinkles", 
            "rhytids", 
            "periorbital"
        ], 
        "lastchanged_date": "August 6, 2013", 
        "number_of_arms": "1", 
        "official_title": "Safety and Efficacy of Non-invasive Dermatologic Procedure With XP200 Radiofrequency for the Primary Treatment of Wrinkles and Rhytids", 
        "overall_official": {
            "affiliation": "BTL Industries Ltd.", 
            "last_name": "Georgi Petkov", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bulgaria: Bulgarian Drug Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "One point or greater improvement in periorbital wrinkle score on a Fitzpatrick scale 3 months after last treatment as determined by at least 2 out of 3 blinded photographs evaluators", 
            "measure": "Improvement in wrinkles appearance", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795417"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "BTL Industries Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "BTL Industries Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}